注射液-话题@MedSci

#注射液#

122篇内容 | 2933人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1586562, encodeId=c7d715865623a, content=<a href='/topic/show?id=f87c6499085' target=_blank style='color:#2F92EE;'>#注射液#</a>, objectTitle=百时美施贵宝公布欧狄沃（纳武利尤单抗注射液）治疗经治非小细胞肺癌患者的长期生存汇总分析结果, objectType=article, longId=163563, objectId=b02416356319, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b02416356319, replyNumber=0, likeNumber=63, createdTime=2019-04-05, rootId=0, userName=shijzhiewnjhch, userId=c93417353045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b02416356319, moduleTitle=百时美施贵宝公布欧狄沃（纳武利尤单抗注射液）治疗经治非小细胞肺癌患者的长期生存汇总分析结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b02416356319)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1586561, encodeId=6013158656158, content=<a href='/topic/show?id=f87c6499085' target=_blank style='color:#2F92EE;'>#注射液#</a>, objectTitle=国家药监局修订通关藤注射液（消癌平注射液）说明书, objectType=article, longId=162713, objectId=0194162e139e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0194162e139e, replyNumber=0, likeNumber=0, createdTime=2019-03-23, rootId=0, userName=shijzhiewnjhch, userId=c93417353045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0194162e139e, moduleTitle=国家药监局修订通关藤注射液（消癌平注射液）说明书, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0194162e139e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1586560, encodeId=e1a5158656060, content=<a href='/topic/show?id=f87c6499085' target=_blank style='color:#2F92EE;'>#注射液#</a>, objectTitle=BMC Gastroenterology：内镜下注射硬化剂与N-Butyl-2氰基丙烯酸酯注射液治疗食管静脉曲张破裂的随机对照试验, objectType=article, longId=160914, objectId=a405160914b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a405160914b8, replyNumber=0, likeNumber=28, createdTime=2019-02-25, rootId=0, userName=shijzhiewnjhch, userId=c93417353045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a405160914b8, moduleTitle=BMC Gastroenterology：内镜下注射硬化剂与N-Butyl-2氰基丙烯酸酯注射液治疗食管静脉曲张破裂的随机对照试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a405160914b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1586559, encodeId=ae161586559ca, content=<a href='/topic/show?id=f87c6499085' target=_blank style='color:#2F92EE;'>#注射液#</a>, objectTitle=刚刚！国家药监局公布：这个注射液，新生儿及婴幼儿禁用, objectType=article, longId=157457, objectId=26e815e45776, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26e815e45776, replyNumber=0, likeNumber=53, createdTime=2019-01-08, rootId=0, userName=shijzhiewnjhch, userId=c93417353045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26e815e45776, moduleTitle=刚刚！国家药监局公布：这个注射液，新生儿及婴幼儿禁用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26e815e45776)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1586558, encodeId=e327158655876, content=<a href='/topic/show?id=f87c6499085' target=_blank style='color:#2F92EE;'>#注射液#</a>, objectTitle=国家药监局修订药品说明书：肿节风注射液禁止静脉给药！, objectType=article, longId=157408, objectId=2aea15e4081c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2aea15e4081c, replyNumber=0, likeNumber=57, createdTime=2019-01-07, rootId=0, userName=shijzhiewnjhch, userId=c93417353045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2aea15e4081c, moduleTitle=国家药监局修订药品说明书：肿节风注射液禁止静脉给药！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2aea15e4081c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1586557, encodeId=3525158655ea7, content=<a href='/topic/show?id=f87c6499085' target=_blank style='color:#2F92EE;'>#注射液#</a>, objectTitle=紧急公告：这个注射液全国停用、召回, objectType=article, longId=157133, objectId=430f15e13379, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=430f15e13379, replyNumber=0, likeNumber=68, createdTime=2019-01-02, rootId=0, userName=shijzhiewnjhch, userId=c93417353045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=430f15e13379, moduleTitle=紧急公告：这个注射液全国停用、召回, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=430f15e13379)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1586556, encodeId=f8fd158655683, content=<a href='/topic/show?id=f87c6499085' target=_blank style='color:#2F92EE;'>#注射液#</a>, objectTitle=国产PD-1抗体药信迪利单抗注射液获批，治疗霍奇金淋巴瘤, objectType=article, longId=156924, objectId=eab61569248c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eab61569248c, replyNumber=0, likeNumber=143, createdTime=2018-12-30, rootId=0, userName=shijzhiewnjhch, userId=c93417353045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eab61569248c, moduleTitle=国产PD-1抗体药信迪利单抗注射液获批，治疗霍奇金淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eab61569248c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1586555, encodeId=d592158655588, content=<a href='/topic/show?id=f87c6499085' target=_blank style='color:#2F92EE;'>#注射液#</a>, objectTitle=抗PD-1单克隆抗体达伯舒®（信迪利单抗注射液）在中国正式获批, objectType=article, longId=156858, objectId=0ef515685842, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ef515685842, replyNumber=0, likeNumber=74, createdTime=2018-12-29, rootId=0, userName=shijzhiewnjhch, userId=c93417353045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ef515685842, moduleTitle=抗PD-1单克隆抗体达伯舒®（信迪利单抗注射液）在中国正式获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ef515685842)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1586554, encodeId=6281158655418, content=<a href='/topic/show?id=f87c6499085' target=_blank style='color:#2F92EE;'>#注射液#</a>, objectTitle=用于治疗乳腺癌的帕妥珠单抗注射液获批上市, objectType=article, longId=156084, objectId=f40f156084d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f40f156084d7, replyNumber=0, likeNumber=0, createdTime=2018-12-19, rootId=0, userName=shijzhiewnjhch, userId=c93417353045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f40f156084d7, moduleTitle=用于治疗乳腺癌的帕妥珠单抗注射液获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f40f156084d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1586553, encodeId=a6dc1586553bc, content=<a href='/topic/show?id=f87c6499085' target=_blank style='color:#2F92EE;'>#注射液#</a>, objectTitle=赫尔森集团与萌蒂中国制药共同宣布，阿洛西®盐酸帕洛诺司琼注射液（ALOXI®）获得国家药品监督管理局批准, objectType=article, longId=155060, objectId=1a8915506025, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a8915506025, replyNumber=0, likeNumber=58, createdTime=2018-12-05, rootId=0, userName=shijzhiewnjhch, userId=c93417353045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a8915506025, moduleTitle=赫尔森集团与萌蒂中国制药共同宣布，阿洛西®盐酸帕洛诺司琼注射液（ALOXI®）获得国家药品监督管理局批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a8915506025)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1586552, encodeId=1213158655218, content=<a href='/topic/show?id=f87c6499085' target=_blank style='color:#2F92EE;'>#注射液#</a>, objectTitle=醒脑静注射液急危重病（症）救治中临床应用专家共识, objectType=article, longId=154473, objectId=81101544e3f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81101544e3f2, replyNumber=0, likeNumber=0, createdTime=2018-11-28, rootId=0, userName=shijzhiewnjhch, userId=c93417353045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81101544e3f2, moduleTitle=醒脑静注射液急危重病（症）救治中临床应用专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81101544e3f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1586551, encodeId=d6e1158655142, content=<a href='/topic/show?id=f87c6499085' target=_blank style='color:#2F92EE;'>#注射液#</a>, objectTitle=欧盟决定保留羟乙基淀粉注射液上市许可并给出了这些建议, objectType=article, longId=151269, objectId=fea7151269ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fea7151269ca, replyNumber=0, likeNumber=55, createdTime=2018-10-19, rootId=0, userName=shijzhiewnjhch, userId=c93417353045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fea7151269ca, moduleTitle=欧盟决定保留羟乙基淀粉注射液上市许可并给出了这些建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fea7151269ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1586550, encodeId=d75b1586550c8, content=<a href='/topic/show?id=f87c6499085' target=_blank style='color:#2F92EE;'>#注射液#</a>, objectTitle=中药注射液“死局”在前，请退出市场！, objectType=article, longId=146418, objectId=e97a1464186a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e97a1464186a, replyNumber=0, likeNumber=88, createdTime=2018-08-13, rootId=0, userName=shijzhiewnjhch, userId=c93417353045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e97a1464186a, moduleTitle=中药注射液“死局”在前，请退出市场！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e97a1464186a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1586549, encodeId=5a3a1586549a2, content=<a href='/topic/show?id=f87c6499085' target=_blank style='color:#2F92EE;'>#注射液#</a>, objectTitle=使用劣药“葡萄糖注射液”，河南中医药大学第一附属医院受处罚, objectType=article, longId=145919, objectId=58c014591960, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58c014591960, replyNumber=0, likeNumber=51, createdTime=2018-08-06, rootId=0, userName=shijzhiewnjhch, userId=c93417353045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58c014591960, moduleTitle=使用劣药“葡萄糖注射液”，河南中医药大学第一附属医院受处罚, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58c014591960)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1586548, encodeId=6342158654809, content=<a href='/topic/show?id=f87c6499085' target=_blank style='color:#2F92EE;'>#注射液#</a>, objectTitle=关于贝伐珠单抗注射液生物类似药临床研究设计及审评的考虑, objectType=article, longId=144371, objectId=70851443e128, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70851443e128, replyNumber=0, likeNumber=0, createdTime=2018-07-15, rootId=0, userName=shijzhiewnjhch, userId=c93417353045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70851443e128, moduleTitle=关于贝伐珠单抗注射液生物类似药临床研究设计及审评的考虑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70851443e128)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1586547, encodeId=7c17158654ed0, content=<a href='/topic/show?id=f87c6499085' target=_blank style='color:#2F92EE;'>#注射液#</a>, objectTitle=注射剂再评价将启动中药注射液企业洗牌加速, objectType=article, longId=142960, objectId=a251142960bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a251142960bf, replyNumber=0, likeNumber=103, createdTime=2018-07-12, rootId=0, userName=shijzhiewnjhch, userId=c93417353045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a251142960bf, moduleTitle=注射剂再评价将启动中药注射液企业洗牌加速, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a251142960bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1586546, encodeId=4dc7158654601, content=<a href='/topic/show?id=f87c6499085' target=_blank style='color:#2F92EE;'>#注射液#</a>, objectTitle=国家药监局发文：儿童禁用柴胡注射液, objectType=article, longId=139474, objectId=f97c1394e4a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f97c1394e4a1, replyNumber=0, likeNumber=76, createdTime=2018-06-01, rootId=0, userName=shijzhiewnjhch, userId=c93417353045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f97c1394e4a1, moduleTitle=国家药监局发文：儿童禁用柴胡注射液, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f97c1394e4a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1586545, encodeId=6924158654506, content=<a href='/topic/show?id=f87c6499085' target=_blank style='color:#2F92EE;'>#注射液#</a>, objectTitle=Biosci Rep：地佐辛注射液与吗啡注射液治疗中国癌症患者持续癌痛的疗效和安全性比较：Meta分析, objectType=article, longId=131439, objectId=75d5131439ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75d5131439ae, replyNumber=0, likeNumber=0, createdTime=2018-03-06, rootId=0, userName=shijzhiewnjhch, userId=c93417353045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75d5131439ae, moduleTitle=Biosci Rep：地佐辛注射液与吗啡注射液治疗中国癌症患者持续癌痛的疗效和安全性比较：Meta分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75d5131439ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1586544, encodeId=cd44158654469, content=<a href='/topic/show?id=f87c6499085' target=_blank style='color:#2F92EE;'>#注射液#</a>, objectTitle=中药注射液--末路来临, objectType=article, longId=130967, objectId=477a13096e29, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=477a13096e29, replyNumber=0, likeNumber=86, createdTime=2018-03-02, rootId=0, userName=shijzhiewnjhch, userId=c93417353045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=477a13096e29, moduleTitle=中药注射液--末路来临, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=477a13096e29)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1586543, encodeId=996a1586543dd, content=<a href='/topic/show?id=f87c6499085' target=_blank style='color:#2F92EE;'>#注射液#</a>, objectTitle=中药注射液监管趋严优秀企业将脱颖而出, objectType=article, longId=130698, objectId=2bf713069891, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bf713069891, replyNumber=0, likeNumber=55, createdTime=2018-02-28, rootId=0, userName=shijzhiewnjhch, userId=c93417353045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bf713069891, moduleTitle=中药注射液监管趋严优秀企业将脱颖而出, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bf713069891)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

注射液

2020-05-29

shijzhiewnjhch (审核中...)

前往app查看评论内容

#注射液#

百时美施贵宝公布欧狄沃（纳武利尤单抗注射液）治疗经治非小细胞肺癌患者的长期生存汇总分析结果

2019-04-05

shijzhiewnjhch (审核中...)

前往app查看评论内容

#注射液#

国家药监局修订通关藤注射液（消癌平注射液）说明书

2019-03-23

shijzhiewnjhch (审核中...)

前往app查看评论内容

#注射液#

BMC Gastroenterology：内镜下注射硬化剂与N-Butyl-2氰基丙烯酸酯注射液治疗食管静脉曲张破裂的随机对照试验

2019-02-25

shijzhiewnjhch (审核中...)

前往app查看评论内容

#注射液#

刚刚！国家药监局公布：这个注射液，新生儿及婴幼儿禁用

2019-01-08

shijzhiewnjhch (审核中...)

前往app查看评论内容

#注射液#

国家药监局修订药品说明书：肿节风注射液禁止静脉给药！

2019-01-07

shijzhiewnjhch (审核中...)

前往app查看评论内容

#注射液#

紧急公告：这个注射液全国停用、召回

2019-01-02

shijzhiewnjhch (审核中...)

前往app查看评论内容

#注射液#

国产PD-1抗体药信迪利单抗注射液获批，治疗霍奇金淋巴瘤

2018-12-30

shijzhiewnjhch (审核中...)

前往app查看评论内容

#注射液#

抗PD-1单克隆抗体达伯舒®（信迪利单抗注射液）在中国正式获批

2018-12-29

shijzhiewnjhch (审核中...)

前往app查看评论内容

#注射液#

用于治疗乳腺癌的帕妥珠单抗注射液获批上市

2018-12-19

shijzhiewnjhch (审核中...)

前往app查看评论内容

#注射液#

赫尔森集团与萌蒂中国制药共同宣布，阿洛西®盐酸帕洛诺司琼注射液（ALOXI®）获得国家药品监督管理局批准

2018-12-05

shijzhiewnjhch (审核中...)

前往app查看评论内容

#注射液#

醒脑静注射液急危重病（症）救治中临床应用专家共识

2018-11-28

shijzhiewnjhch (审核中...)

前往app查看评论内容

#注射液#

欧盟决定保留羟乙基淀粉注射液上市许可并给出了这些建议

2018-10-19

shijzhiewnjhch (审核中...)

前往app查看评论内容

#注射液#

中药注射液“死局”在前，请退出市场！

2018-08-13

shijzhiewnjhch (审核中...)

前往app查看评论内容

#注射液#

使用劣药“葡萄糖注射液”，河南中医药大学第一附属医院受处罚

2018-08-06

shijzhiewnjhch (审核中...)

前往app查看评论内容

#注射液#

关于贝伐珠单抗注射液生物类似药临床研究设计及审评的考虑

2018-07-15

shijzhiewnjhch (审核中...)

前往app查看评论内容

#注射液#

注射剂再评价将启动中药注射液企业洗牌加速

2018-07-12

shijzhiewnjhch (审核中...)

前往app查看评论内容

#注射液#

国家药监局发文：儿童禁用柴胡注射液

2018-06-01

shijzhiewnjhch (审核中...)

前往app查看评论内容

#注射液#

Biosci Rep：地佐辛注射液与吗啡注射液治疗中国癌症患者持续癌痛的疗效和安全性比较：Meta分析

2018-03-06

shijzhiewnjhch (审核中...)

前往app查看评论内容

#注射液#

中药注射液--末路来临

2018-03-02

shijzhiewnjhch (审核中...)

前往app查看评论内容

#注射液#

中药注射液监管趋严优秀企业将脱颖而出

2018-02-28

科室
- - 订阅+
  - 更多科室
工具
服务